Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Clinical Outcomes of Mpox Disease in Patients Treated With Tecovirimat.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 30, 2025
Clinical Outcomes of Mpox Disease in Patients Treated with Tecovirimat.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 30, 2025
Fixed dosing versus weight-based dosing of HIV-1 prophylactic monoclonal antibodies in adults: a post-hoc, cross-protocol pharmacokinetics modelling study.
Journal: EBioMedicine
Published: January 09, 2025
Pharmacokinetic interaction assessment of an HIV broadly neutralizing monoclonal antibody VRC07-523LS: a cross-protocol analysis of three phase 1 trials in people without HIV.
Journal: BMC immunology
Published: October 22, 2024
Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial Sexually Transmitted Infections: A Secondary Analysis of HPTN 083.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: September 16, 2024
Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial STIs: A Secondary Analysis of HPTN 083.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: September 16, 2024
Safety, tolerability, pharmacokinetics, and immunological activity of dual-combinations and triple-combinations of anti-HIV monoclonal antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS administered intravenously to HIV-uninfected adults: a phase 1 randomised trial.
Journal: The lancet. HIV
Published: October 21, 2022
COVID-19 Vaccine Uptake and Factors Associated With Being Unvaccinated Among Lesbian, Gay, Bisexual, Transgender, Queer, and Other Sexual Identities (LGBTQ+) New Yorkers.
Journal: Open forum infectious diseases
Published: March 30, 2022
Development and Validation of the Personalized Sexual Health Promotion (SexPro) HIV Risk Prediction Model for Men Who Have Sex with Men in the United States.
Journal: AIDS and behavior
Published: July 29, 2019
Short- and Long-Term Pharmacologic Measures of HIV Pre-exposure Prophylaxis Use Among High-Risk Men Who Have Sex With Men in HPTN 067/ADAPT.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: July 24, 2019
Low Disclosure of PrEP Nonadherence and HIV-Risk Behaviors Associated With Poor HIV PrEP Adherence in the HPTN 067/ADAPT Study.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: June 07, 2019
Last Updated: 09/26/2026